Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management

2007 ◽  
Vol 33 (9) ◽  
pp. 1061-1067 ◽  
Author(s):  
G. Corso ◽  
F. Roviello ◽  
J. Paredes ◽  
C. Pedrazzani ◽  
M. Novais ◽  
...  
2005 ◽  
Vol 11 (15) ◽  
pp. 5401-5409 ◽  
Author(s):  
Gianpaolo Suriano ◽  
Sandie Yew ◽  
Paulo Ferreira ◽  
Janine Senz ◽  
Pardeep Kaurah ◽  
...  

2018 ◽  
Vol 19 (10) ◽  
pp. 3099 ◽  
Author(s):  
Anna Malekkou ◽  
Maura Samarani ◽  
Anthi Drousiotou ◽  
Christina Votsi ◽  
Sandro Sonnino ◽  
...  

The GBA2 gene encodes the non-lysosomal glucosylceramidase (NLGase), an enzyme that catalyzes the conversion of glucosylceramide (GlcCer) to ceramide and glucose. Mutations in GBA2 have been associated with the development of neurological disorders such as autosomal recessive cerebellar ataxia, hereditary spastic paraplegia, and Marinesco-Sjogren-Like Syndrome. Our group has previously identified the GBA2 c.1780G>C [p.Asp594His] missense mutation, in a Cypriot consanguineous family with spastic ataxia. In this study, we carried out a biochemical characterization of lymphoblastoid cell lines (LCLs) derived from three patients of this family. We found that the mutation strongly reduce NLGase activity both intracellularly and at the plasma membrane level. Additionally, we observed a two-fold increase of GlcCer content in LCLs derived from patients compared to controls, with the C16 lipid being the most abundant GlcCer species. Moreover, we showed that there is an apparent compensatory effect between NLGase and the lysosomal glucosylceramidase (GCase), since we found that the activity of GCase was three-fold higher in LCLs derived from patients compared to controls. We conclude that the c.1780G>C mutation results in NLGase loss of function with abolishment of the enzymatic activity and accumulation of GlcCer accompanied by a compensatory increase in GCase.


2015 ◽  
Vol 14 (7) ◽  
pp. 2872-2883 ◽  
Author(s):  
Ehwang Song ◽  
Yunli Hu ◽  
Ahmed Hussein ◽  
Chuan-Yih Yu ◽  
Haixu Tang ◽  
...  

Cell Cycle ◽  
2009 ◽  
Vol 8 (20) ◽  
pp. 3396-3405 ◽  
Author(s):  
Michela Muscolini ◽  
Elisa Montagni ◽  
Silvana Caristi ◽  
Takao Nomura ◽  
Rui Kamada ◽  
...  

2011 ◽  
Vol 164 (6) ◽  
pp. 927-936 ◽  
Author(s):  
Sigri Beckers ◽  
Fenna de Freitas ◽  
Doreen Zegers ◽  
An Verrijken ◽  
Armand V Peeters ◽  
...  

ObjectiveIn this study, we hypothesized that mutations in the resistin encoding gene, RETN, may cause a monogenic form of obesity.Design/methodsWe screened the coding region of RETN in 81 morbidly obese adults, 263 overweight and obese children/adolescents, and 116 healthy lean subjects. In vitro experiments include qPCR, ELISA, and western blot for WT and mutant resistin transfected into 3T3-L1 adipocytes.ResultsMutation analysis identified five sequence variants in our patient populations: 3′-UTR +87 G/A, 3′-UTR +100 A/G, T73T, IV3-61 C/A, and C78S. In our control population, we only found the 3′-UTR +87 G/A variant. We started functional experiments for the C78S mutation that was found in a 20-year-old obese male (body mass index (BMI)=39.7 kg/m2) and his obese mother (BMI=31.9 kg/m2). In vitro testing demonstrated that the mutation does not impair mRNA expression. We identified a 100-fold lower extracellular protein concentration for mutant resistin compared with WT levels using a resistin ELISA on cell culture medium (P=4.87×10−6). We also detected a decreased intracellular concentration for the mutant protein (tenfold lower relative levels, P=0.007). The plasma resistin levels of the proband and his mother, however, did not differ significantly from lean control individuals.ConclusionsIn conclusion, we identified the first missense mutation in resistin in a morbidly obese proband and his obese mother. Functional testing of the mutant protein suggests that the C78S mutant protein is degraded, possibly resulting in a decreased extracellular concentration, which may predispose to obesity.


2013 ◽  
Vol 12 (4) ◽  
pp. 207-211 ◽  
Author(s):  
Fakhri Kallabi ◽  
Ikhlass Hadj Salem ◽  
Ghada Ben Salah ◽  
Hadhami Ben Turkia ◽  
Amel Ben Chehida ◽  
...  

Biochemistry ◽  
2009 ◽  
Vol 48 (4) ◽  
pp. 699-708 ◽  
Author(s):  
Nicole J. Moreland ◽  
Caroline Charlier ◽  
Andrew J. Dingley ◽  
Edward N. Baker ◽  
J. Shaun Lott

Sign in / Sign up

Export Citation Format

Share Document